NOCILNSENOCIL Limited· Chemicals - SpecialityMediumNeutral
Announced Fri, 23 May · 11:26 IST

NOCIL Limited has informed the Exchange about Transcript

Mgmt Guided Margin ImprovementMgmt Evaded Key QuestionInvestor Communications View source PDF

NOCIL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

NOCIL reported Q4 FY25 revenue of Rs. 340 crores, up 7% sequentially, with volumes growing 4% quarter-on-quarter. Full-year FY25 revenue stood at Rs. 1,393 crores versus Rs. 1,445 crores in FY24, while annual operating EBITDA fell to Rs. 137 crores (9.9% margin) from Rs. 195 crores, and profit after tax declined to Rs. 103 crores from Rs. 133 crores. Management cited continued pricing pressure from dumping by Chinese, Korean, and EU rubber chemical manufacturers, and noted a newly filed antidumping petition covering about 40% of the business. The Rs. 250 crore capex at Dahej for TDQ antioxidants is on track, and overall capacity utilisation was indicated at around 65-70%. The management acknowledged that recent performance has not met aspirations but remains positive on medium-to-long-term growth, supported by a 4-6% projected CAGR for the Indian tire industry.

Likely market impact

For shareholders, the call signals that near-term profitability remains under pressure from import dumping and legacy inventory costs, though management expects a marginal improvement in margins going forward. The antidumping outcome (expected within ~9 months) and Dahej expansion progress will be key catalysts to watch for any meaningful re-rating.